House Antidepressant Hearing Rescheduled For Sept. 9
This article was originally published in The Pink Sheet Daily
Executive Summary
The hearing was postponed from July 20 when former subcommittee Chairman Greenwood accepted a position as BIO president. Witnesses could include seven antidepressant manufacturers.
You may also be interested in...
Antidepressant Suicidality Class Risk Will Be Reviewed By Advisory Committees
FDA releases analysis of pediatric suicidality data for joint meeting of Psychopharmacologic Drugs and Pediatric Advisory Committees. The analysis could result in label changes for antidepressants, FDA Talk Paper says.
Antidepressant Suicidality Class Risk Will Be Reviewed By Advisory Committees
FDA releases analysis of pediatric suicidality data for joint meeting of Psychopharmacologic Drugs and Pediatric Advisory Committees. The analysis could result in label changes for antidepressants, FDA Talk Paper says.
Rep. Greenwood Will Join BIO In January
The Pennsylvania Republican will serve out his term before becoming president of the trade association. Greenwood emphasizes the promise of stem cell research as a reason for taking the Biotechnology Industry Organization post.